Viewing Study NCT00190502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-01-29 @ 3:25 AM
Study NCT ID: NCT00190502
Status: UNKNOWN
Last Update Posted: 2007-01-09
First Post: 2005-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
Sponsor: Institute for Clinical and Experimental Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 1 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 1 diabetes mellitus View
None Immune intervention View
None Polyclonal antibodies View
None Type 1 diabetes of recent onset View
None C-peptide level 0.3 pmol/l or higher View
None Positivity of at least one marker of autoimmunity (diabetes) View